Literature DB >> 24124823

Lichen planopilaris treated by the peroxisome proliferator activated receptor-γ agonist pioglitazone: lack of lasting improvement or cure in the majority of patients.

Philipp Spring1, Zoi Spanou2, Pierre A de Viragh3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24124823     DOI： 10.1016/j.jaad.2013.04.066

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  6 in total

Review 1.  A Practical Approach to the Diagnosis and Management of Classic Lichen Planopilaris.

Authors:  Katerina Svigos; Lu Yin; Lauren Fried; Kristen Lo Sicco; Jerry Shapiro
Journal:  Am J Clin Dermatol       Date:  2021-08-04       Impact factor: 7.403

Review 2.  Frontal Fibrosing Alopecia: A Review.

Authors:  María Librada Porriño-Bustamante; María Antonia Fernández-Pugnaire; Salvador Arias-Santiago
Journal:  J Clin Med       Date:  2021-04-21       Impact factor: 4.241

Review 3.  Therapeutic management of classic lichen planopilaris: a systematic review.

Authors:  Enzo Errichetti; Matteo Figini; Margherita Croatto; Giuseppe Stinco
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-02-27

4.  Association of type 2 diabetes with central-scalp hair loss in a large cohort study of African American women.

Authors:  Patricia F Coogan; Traci N Bethea; Yvette C Cozier; Kimberly A Bertrand; Julie R Palmer; Lynn Rosenberg; Yolanda Lenzy
Journal:  Int J Womens Dermatol       Date:  2019-06-06

Review 5.  Pathomechanisms of immune-mediated alopecia.

Authors:  Alessandra Anzai; Eddy Hsi Chun Wang; Eunice Y Lee; Valeria Aoki; Angela M Christiano
Journal:  Int Immunol       Date:  2019-07-13       Impact factor: 5.071

Review 6.  PPAR-γ Agonists and Their Role in Primary Cicatricial Alopecia.

Authors:  Sarawin Harnchoowong; Poonkiat Suchonwanit
Journal:  PPAR Res       Date:  2017-12-03       Impact factor: 4.964
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.